Combined anti-interleukin-2 receptor and low-dose cyclosporine therapy in experimental autoimmune uveoretinitis

This publication has 19 references indexed in Scilit:

• Current Stage of Interleukin 2 Receptor Targeted Therapy¹)
  Experimental and Clinical Endocrinology & Diabetes, 1989
• Multichain Interleukin-2 Receptor: A Target for Immunotherapy in Lymphoma
  JNCI Journal of the National Cancer Institute, 1989
• Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases
  Clinical Immunology and Immunopathology, 1989
• Immunotherapy of experimental autoimmune encephalomyelitis (EAE): Differential effect of anti-IL-2 receptor antibody therapy on actively induced and T-line mediated EAE of the Lewis rat
  Journal of Autoimmunity, 1989
• Effect of cyclosporin on interleukin 2-related T-lymphocyte parameters in IDDM patients
  Diabetes, 1989
• Phenotypical characterization of the cells invading pancreatic islets of diabetic BB/OK rats: effect of interleukin 2 receptor-targeted immunotherapy
  European Journal of Immunology, 1988
• Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts
  European Journal of Immunology, 1987
• Renal Histopathologic Alterations in Patients Treated with Cyclosporine for Uveitis
  New England Journal of Medicine, 1986
• Antibody determination by ELISA in rats with retinal S antigen-induced uveoretinitis
  Current Eye Research, 1982
• Vaccination against autoimmune encephalomyelitis (EAE): Attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line
  European Journal of Immunology, 1981